Objective: The objective of this study was to determine whether blacks with lower extremity peripheral artery disease (PAD) have faster functional decline than whites with PAD.
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Questions Society for Vascular Surgery Phone: 800-258-7188; education@vascularsociety.org adjustment for income and education (P ¼ .229). Among 844 participants without baseline mobility impairment, black participants had a higher rate of mobility loss (64/209 [30.6%] vs 164/635 [25.8%]; log-rank, P ¼ .009). Black race was associated with increased mobility loss, adjusting for potential confounders (hazard ratio, 1.42; 95% confidence interval, 1.04-1.94; P ¼ .028). This association was attenuated after additional adjustment for income and education (P ¼ .392) and physical activity (P ¼ .113). There were no racial differences in average annual declines in 6-minute walk, usual-paced 4-meter walking velocity, or fast-paced 4-meter walking velocity.
Conclusions: Black PAD patients have higher rates of mobility loss and becoming unable to walk for 6 minutes continuously. These differences appear related to racial differences in socioeconomic status and physical activity. (J Vasc Surg 2017; 66:826-34.) Racial disparities in treatment are well established in people with lower extremity peripheral artery disease (PAD) and critical limb ischemia. [1] [2] [3] [4] [5] [6] Black patients with critical limb ischemia are less likely to undergo revascularization and more likely to have amputations than are white patients with critical limb ischemia. [1] [2] [3] [4] [5] [6] To our knowledge, no longitudinal studies have compared mobility loss or functional decline between blacks and whites with PAD and without critical limb ischemia. Therefore, we compared mobility loss and objectively measured functional decline between blacks and whites with PAD. On the basis of prior cross-sectional study 7 and studies of people with critical limb ischemia, [1] [2] [3] [4] [5] [6] we hypothesized that black participants with PAD would have faster functional decline than white participants with PAD.
METHODS

Study overview
Data from four prospective observational studies of patients with PAD were combined. Participants were identified from the Walking and Leg Circulation Study (WALCS), WALCS II, WALCS III, and Biomarker Risk Assessment in Vulnerable Outpatients (BRAVO) study [8] [9] [10] [11] [12] [13] (Table I) . In all studies, participants were recruited from Chicago-area medical centers and observed longitudinally. [8] [9] [10] [11] [12] [13] Details of recruitment have been reported. [8] [9] [10] [11] [12] [13] Participants with PAD were identified from noninvasive vascular laboratories at multiple Chicago-area hospitals using lists of all patients who underwent lower extremity arterial testing during specific periods and contacting those with abnormal results consistent with PAD. Participants with PAD were also identified from vascular surgery, cardiology, general medicine, endocrinology, and geriatric clinics at Chicago-area hospitals using International Classification of Diseases, Ninth Revision codes to identify all patients with PAD who attended a clinic visit during specific periods. The study protocol conforms to the ethical guidelines of the 1975 Declaration of Helsinki. The Institutional Review Boards of Northwestern University and all participating medical centers approved the protocol. All participants gave written informed consent. In the WALCS, WALCS II, and WALCS III cohorts, participants completed baseline testing and returned annually for up to four follow-up visits. At each annual visit, the ankle-brachial index (ABI) and objective measures of lower extremity functioning were repeated. Questionnaires were readministered to obtain data each year on mobility impairment and current health including hospitalizations since the most recent study visit. In BRAVO, participants completed baseline testing and returned every 6 months for functional measures for up to 3 years. The ABI was not repeated after baseline in the BRAVO cohort, but questionnaires were administered every 6 months to obtain information about the participant's health, mobility impairment, and hospitalizations since the most recent visit.
Inclusion criterion
All participants in these analyses had a baseline ABI <0.90.
Exclusion criteria
In all studies, patients with dementia were excluded because of their inability to answer questions accurately. Nursing home residents were excluded because they had severely impaired functioning at baseline. NonEnglish-speaking patients were excluded because investigators were not fluent in non-English languages. Patients with recent major surgery were excluded because the surgery may have influenced their baseline mobility. In the WALCS, WALCS II, and WALCS III cohorts, participants who were wheelchair bound or who had history of leg or foot amputations were excluded because of their severe functional impairment at baseline. Potential participants with toe or partial foot amputations were allowed to participate. In the WALCS III cohort, participants with contraindications to magnetic resonance imaging testing were excluded. We did not systematically exclude potential participants with critical limb ischemia; however, participants with mobility disability or inability to perform the 6-minute walk tests at baseline were not included in the mobility or 6-minute walk outcome measures, respectively.
ABI measurement
A trained and certified research coordinator used a hand-held Doppler probe (Nicolet Vascular Pocket-Dop II; Nicolet Biomedical Inc, Golden, Colo) to measure systolic pressures in the right and left brachial, dorsalis pedis, and posterior tibial arteries. 14, 15 Research coordinators were trained by a senior staff member and certified by the principal investigator (M.M.M.) before collecting data from research subjects. Each pressure was measured twice. For each leg, the ABI was calculated by dividing the mean of the dorsalis pedis and posterior tibial pressures by the mean of the four brachial pressures because previous study shows that this method of ABI calculation is most closely associated with the degree of functional impairment in PAD. 15 The leg with the lowest ABI was used in analyses. The coefficient of variation percentage for the test-retest reliability was 5.2% in WALCS, 10.4% in WALCS II, 7.5% in WALCS III, and 9.5% in the BRAVO cohort.
Race
Information on race was obtained from participants by questionnaire. Participants who were not black or white were excluded from these analyses.
Outcomes
Mobility outcome. At baseline and at each follow-up visit, participants were asked whether they were able to walk up and down stairs to the second floor and to walk ¼ mile (three blocks) on their own, with help, or not at all. Incident mobility impairment, defined here as mobility loss, consisted of reporting inability to walk up and down one flight of stairs or to walk ¼ mile either at all or without assistance during follow-up among participants without mobility impairment at baseline. [16] [17] [18] The participant's report of mobility is valid and reliable. [19] [20] [21] For example, in 193 men and women aged 69 years and older who were interviewed twice, 3 weeks apart, about their mobility (measured as their ability to climb a flight of stairs and to walk ¼ mile without assistance), agreement was 89% during the two independent assessments performed 3 weeks apart. Among participants with PAD, a randomized clinical trial reported that home-based exercise prevented mobility loss at 6-month follow-up, and findings were consistent at 12-month follow-up. 22 Additional evidence from PAD participants shows that greater decline in the 6-minute walk during 2-year follow-up is associated with higher rates of subsequent mobility loss. 23 Six-minute walk The 6-minute walk test was performed at baseline using a standardized and well-validated protocol. 8, 9, 12, 16 Participants walked up and down a 100-foot hallway for 6 minutes after instructions to cover as much distance as possible. We recorded at baseline and follow-up whether participants stopped to rest for at least 5 seconds at least once during the 6 minutes. Cardiac monitoring is not performed during the 6-minute walk test. Serious adverse events during the 6-minute walk occur at a rate of <1 in 7900 tests. 22 
Four-meter walking velocity
Participants were timed walking a 4-meter distance after instructions to walk at their usual pace and fastest pace, respectively. Usual-paced and fast-paced 4-meter walking velocity each predict mortality and mobility loss in people with and without PAD. 16, 17, 24 Comorbidities
Comorbidities assessed at baseline were diabetes, angina, myocardial infarction, heart failure, cancer, chronic lung disease, knee arthritis, hip arthritis, spinal stenosis, disk disease, and stroke. Disease-specific algorithms that combine data from patient report, medical record review, medications, laboratory values, and a questionnaire completed by the participant's primary care physician were used to verify and to document baseline comorbidities. 25, 26 The primary care physician questionnaire response rate was 78%, but the investigative team directly telephoned primary care physicians who did not return the questionnaire.
Leg symptoms
Leg symptoms were classified using the San Diego claudication questionnaire. 27 Intermittent claudication (IC) was defined as exertional calf pain that did not begin at rest, caused the patient to stop walking, and resolved within 10 minutes of rest. [7] [8] [9] 27 Participants without IC either reported no exertional leg symptoms (asymptomatic PAD) or had leg symptoms other than IC. [7] [8] [9] 27 For example, participants with leg symptoms other than IC could have exertional leg pain that does not involve the calf or that requires >10 minutes to resolve after rest.
Socioeconomic status
We used income and education level to classify participants' socioeconomic status. Participants were asked their highest level of education, using a questionnaire administered by certified interviewers. Responses were categorized according to the participant's report of the highest attained level of education, as follows: less than high school, high school through college, or at least some graduate school. Each participant's income was categorized as either above or below the median income for the cohort, based on the participant's zip code, using United States Census data linking zip code to income. 28 Take Home Message: Of 1162 participants with peripheral artery disease, observed for a median of 46.0 months, the 305 black participants had higher rates of mobility loss and higher rates of becoming unable to walk for 6 minutes continuously. These differences appeared to be related to racial differences in socioeconomic status and physical activity. Recommendation: The authors suggest that black patients with peripheral artery disease have a more rapid functional decline than whites do, but these differences largely disappear when education and socioeconomic status are taken into account.
ARTICLE HIGHLIGHTS
Physical activity level
Patient-reported physical activity was measured with a questionnaire derived from the Harvard Alumni Activity Survey that has been previously validated. [29] [30] [31] The physical activity question asked, "During the last week, how many city blocks or their equivalent did you walk? Let 12 city blocks equal 1 mile."
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Other measures Height and weight were measured at baseline. Body mass index (BMI) was calculated as weight (kilograms)/ (height [meters]). 2 Cigarette smoking history was determined with the patient's report. suprainguinal procedures) were censored at the time of death or revascularization. Repeated-measures mixed models were used to compare average annual decline in 6-minute walk, 4-meter walking velocity at usual pace, and 4-meter walking velocity at fast pace, adjusting for age, sex, race, study cohort, BMI, smoking, comorbidities, leg symptoms, prior year performance, and ABI. Analyses were performed using SAS statistical software (version 9.4; SAS Institute, Cary, NC).
Statistical analyses
RESULTS
Of 1413 participants with an ABI <0.90 enrolled in the WALCS, WALCS II, WALCS III, and BRAVO cohorts, 60 did not classify themselves as either black or white, 54 died before the first follow-up visit, 44 were lost to follow-up, 54 returned for follow-up but did not repeat the outcome measures reported here, and 39 were missing one or more covariates, leaving 1162 for analyses. Of these, 857 (74%) were white and 305 (26%) were black. Median follow-up Compared with whites, blacks with PAD were younger and had a lower ABI value, had a higher BMI, achieved lower education, and had a lower median household income (Table II) . Compared with whites, blacks with PAD had a lower prevalence of cancer and higher prevalences of stroke, diabetes, current smoking, and hypertension (Table II) . Compared with whites with PAD, blacks with PAD had a lower prevalence of claudication symptoms, lower physical activity, and poorer functional performance at baseline (Table II) .
In unadjusted analyses, blacks had a higher cumulative probability of mobility loss compared with whites (64/ 209 [30.6%] vs 164/635 [25.8%]; log-rank, P ¼ .009; Fig 1) . Adjusting for age, sex, ABI, BMI, smoking, comorbidities, leg symptoms, and study cohort, black PAD participants had an increased hazard of mobility loss compared with white PAD participants (hazard ratio [HR], 1.42; 95% confidence interval [CI], 1.04-1.94; P ¼ .028). This association was not statistically significant after additional adjustment for income and education (P ¼ .392) or after additional adjustment for physical activity (P ¼ .113), respectively (Table III) . There was no significant interaction of study cohort in the association of race and mobility loss, also suggesting that the association did not change over time.
In unadjusted analyses, blacks had a higher cumulative probability of becoming unable to walk for 6 minutes continuously compared with whites (64/171 [37.4%] vs 156/540 [28.9%]; log-rank, P ¼ .006; Fig 2) . Adjusting for age, sex, ABI, BMI, smoking, comorbidities, leg symptoms, and cohort, black PAD participants had a higher rate of becoming unable to walk for 6 minutes without stopping compared with whites (HR, 1.45; 95% CI, 1.05-1.99; P ¼ .022). This association was not statistically significant after additional adjustment for income and education (P ¼ .229; Table III ). The association remained statistically significant, however, after additional adjustment for baseline physical activity (P ¼ .036; Table III ). There was no significant interaction of study cohort in the association of race and becoming unable to walk for 6 minutes continuously, suggesting that the association of race with the ability to walk for 6 minutes continuously did not change over time. Results shown in Table III were not substantially changed when analyses were repeated adjusting for the ABI in which the highest of the dorsalis pedis and posterior tibial pressures was used in the numerator and the highest of the left vs right brachial artery pressure was used in the denominator. In analyses adjusting for age, sex, ABI, BMI, smoking, comorbidities, leg symptoms, study cohort, and prior year performance, there was no difference between white and black PAD participants in average annual decline in the 6-minute walk distance (À56.0 vs À47.9 feet per year, respectively; P ¼ .394), usual-paced 4-meter walking velocity (À0.023 vs À0.030 m/s, respectively; P ¼ .256), or fast-paced 4-meter walking velocity (À0.038 vs À0.047 m/s, respectively; P ¼ .240).
Because the Kaplan-Meier curve suggested that mobility loss was greatest during the first year of follow-up, we conducted post hoc analyses in which we analyzed the association of black race with mobility loss during the first year vs after the first year of followup. Rates of mobility loss during the first year of followup (ie, within 13 months after enrollment) were 8.2% (52/635) for white PAD participants and 16.8% (35/209) for black PAD participants (P < .001). Adjusting for age, sex, ABI, BMI, smoking, comorbidities, leg symptoms, and study cohort, black PAD participants had an increased risk of mobility loss compared with white PAD participants during the first year of follow-up (HR, 1.99; 95% CI, 1.25-3.16; P ¼ .004). This association was no longer statistically significant after additional adjustment for income and education status (P ¼ .102) but remained statistically significant after additional adjustment for physical activity level (P ¼ .011). When we separately analyzed rates of mobility loss after the first year of follow-up, there was no difference between whites and blacks in risk of mobility loss (mobility loss, 112/502 [22.3%] vs 29/133 [21.8%]; P ¼ .901). Adjusting for age, sex, race, study cohort, comorbidities, ABI, BMI, leg symptoms, and smoking, the HR for mobility loss in blacks vs whites after the first year of follow-up was 1.02 (95% CI, 0.66-1.59; P ¼ .927).
DISCUSSION
In 1162 participants with PAD identified from Chicagoarea medical centers and followed up prospectively, black participants had higher rates of mobility loss and a higher rate of becoming unable to walk for 6 minutes without stopping compared with whites during 46 months of follow-up. These findings were independent of adjustment for age, sex, ABI, smoking, comorbidities, and other confounders. After additional adjustment for income and education, racial differences in mobility loss and becoming unable to walk for 6 minutes continuously were not observed. Our findings suggest that racial differences in income and education level may explain racial differences in rates of mobility loss and becoming unable to walk for 6 minutes continuously among people with PAD. Blacks also had lower physical activity than whites, which may be related to lower baseline ABI values in blacks vs whites or may be related to racial differences in environment or priorities. After adjusting for physical activity, the association of black race with mobility loss was no longer observed. However, the association of black race with becoming unable to walk for 6 minutes continuously remained statistically significant. This finding suggests that race differences in physical activity may explain some but not all of the racial differences in functional decline observed here.
Prior studies assessed associations of black race with amputation and revascularization rates in PAD patients with critical limb ischemia. [1] [2] [3] [4] [5] [6] 33 Lefebvre and Chevan used the Nationwide Inpatient Survey to study patients hospitalized with PAD between 2002 and 2011. Black race was associated with higher rates of transfemoral amputation compared with nonblack race, and this disparity did not change during the 10-year period of the study, even as overall amputation rates declined. 33 Using data from the Nationwide Inpatient Survey, Henry et al 2 reported that among 958,120 patients hospitalized with critical limb ischemia between 2002 and 2007, black patients were more likely than whites to undergo amputation, whereas white patients were more likely to undergo lower extremity revascularization. Racial differences in socioeconomic status and access to medical care have been cited as potential explanations for racial differences in amputation rates. However, one recent study reported racial differences in management of critical limb ischemia even within hospitals with advanced revascularization capabilities or located in wealthy zip codes. 1 Currently, evidence is conflicting as to whether racial differences in outcomes are explained by racial differences in factors such as socioeconomic status and education. Our findings suggest that racial differences in functional decline among people with PAD are largely explained by differences in socioeconomic status, education, and physical activity levels.
To our knowledge, no prior longitudinal studies have compared differences between blacks and whites in rates of functional decline or mobility loss in people with PAD who do not have critical limb ischemia. Lower income and education status in blacks with PAD may mediate our findings of racial differences in mobility loss and becoming unable to walk for 6 minutes continuously if PAD patients with lower education and income have less access to healthy lifestyles, such as healthy diet and opportunities for regular exercise, and less access to optimal medical care. For these reasons, black patients may present at a later stage of PAD compared with white patients. Consistent with this hypothesis, black participants with PAD had lower baseline ABI values than white participants with PAD. Similarly, in a singlecenter study, black patients with critical limb ischemia had more severe PAD than white patients with critical limb ischemia. 34 We also found that black PAD participants had lower physical activity levels at baseline compared with whites and that lower physical activity levels partly explained higher rates of mobility loss in black PAD participants. We did not identify differences in rates of average annual decline in 6-minute walk distance or 4-meter walking velocity between black and white participants with PAD. There are several potential explanations for these findings. First, it is possible that lower baseline performance in the 6-minute walk and 4-meter walking velocity among black PAD participants resulted in a floor effect, in which further declines in walking performance from baseline among participants were less likely. Second, it is possible that black PAD participants with the greatest declines in 6-minute walk and 4-meter walking velocity were less likely to return for follow-up testing than white PAD participants, resulting in the inability to detect racial differences in decline in 6-minute walk and 4-meter walking velocity. Third, it is possible that there is a threshold effect for decline in the 6-minute walk and 4-meter walking velocity that black participants had already crossed at the time of study enrollment.
Our study has limitations. First, we cannot discern the specific causal pathway by which lower income, education, and physical activity levels among blacks mediate the racial differences in decline reported here. Second, there may be unmeasured confounders. Third, we did not measure severity of comorbidities at baseline. Fourth, our measure of physical activity was based on the patient's self-report. It is possible that an objective measure of physical activity may have altered our conclusions about the importance of physical activity as a mediator of racial differences in mobility loss. Fifth, the mobility loss measure is a patient-reported measure. Although the mobility loss outcome is a well-validated measure of ability to walk ¼ mile and to walk up and down a flight of stairs without assistance, [19] [20] [21] some small crosssectional studies suggest that patients with PAD do not accurately report their actual pain-free walking distance. 35, 36 Sixth, we did not assess presence of chronic kidney disease. Seventh, some of the racial differences in functional decline may have been attributable to more severe PAD among the black participants, which may not have been precisely measured by the ABI, particularly given the higher prevalence of diabetes mellitus among black PAD participants.
CONCLUSIONS
Black patients with PAD have higher rates of mobility loss and higher rates of becoming unable to walk for 6 minutes continuously compared with white patients with PAD. These differences appear to be explained by lower socioeconomic status in blacks compared with whites with PAD. Racial differences in physical activity also appear to contribute to findings reported here. Further study is needed to determine whether interventions that increase physical activity levels in blacks and reduce racial disparities in income and education can eliminate racial differences in mobility loss in PAD. Recent evidence demonstrates that a home-based walking exercise intervention reduces mobility loss in patients with PAD. 23 Further study is needed to determine whether increasing access of all PAD patients to homebased exercise programs can reduce the racial difference in mobility loss reported here.
